Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. (Q34421486)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

0 references

1 reference

title

Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

T Lind

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

L Lundell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

1729-1736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683686%20AND%20SRC:MED&resulttype=core&format=json

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X

Economic evaluation of long-term management strategies for erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01128.X